InvestSMART

Alterity Therapeutics Limited (ASX:ATH)

ALERT: Price-sensitive ASX Announcement for ATH
Current share price for ATH : $0.240 -0.28 (-53.85%)+
Announcement
Release
31 Aug 2026 9:51AM
Price at Release
$0.520
Full Release
download
Summary
Alterity Therapeutics Limited announced that it has executed an underwriting agreement with MST Financial Services Pty Ltd to underwrite the exercise shortfall of up to 8,400,000 ATHO listed options expiring at 5:00pm AEST on 31 August 2026, with the underwritten portion expected to raise approximately A$4.2 million before costs and total potential proceeds from all option exercises ranging from about A$4.2 million to A$7.96 million before costs. The options are exercisable at A$0.50 each, and any shortfall shares will be subscribed for by the underwriter or its sub-underwriters, with MST to receive a 7% underwriting fee on gross proceeds from the underwritten options. Alterity said the funds are intended to support the continued late-stage clinical development of ATH434 in Multiple System Atrophy, including preparation for its planned Phase 3 pivotal trial, as well as general working capital. The announcement also notes that the underwriter is not a related party, the agreement is subject to customary conditions and termination events, and completion of the underwriting is not guaranteed.
Key Points
  • Alterity Therapeutics entered into an underwriting agreement with MST Financial Services Pty Ltd for ATHO listed options.
  • The underwriting covers up to 8,400,000 unexercised ATHO options ahead of their expiry on 31 August 2026.
  • The underwritten options are expected to raise approximately A$4.2 million before costs.
  • There were 15,918,235 ATHO listed options on issue, exercisable at A$0.50 each.
  • Total proceeds from option exercises and underwriting could range from approximately A$4.2 million to A$7.96 million before costs.
  • Funds are intended to support late-stage clinical development of ATH434 in Multiple System Atrophy and general working capital.
  • MST Financial Services Pty Ltd will receive an underwriting fee of 7% of gross proceeds raised from the underwritten options.
  • The underwriter is not a related party of the company under ASX Listing Rule 3.11.3.
  • The underwriter has sub-underwriting arrangements with sophisticated and professional investors.
  • The underwriting agreement includes customary conditions and termination events, so completion is not guaranteed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.